Estrogen receptors in brain tumors

Area of Science:

• Neuro-oncology
• Endocrinology

Background:

• Estrogen receptors (ER) play a role in various physiological processes.
• The presence and role of ER in brain tumors are not fully understood.

Purpose of the Study:

• To investigate the presence and levels of cytosolic and nuclear estrogen receptors in different types of brain tumors.
• To determine if brain tumors exhibit estrogen receptor activity, suggesting potential estrogen responsiveness.

Main Methods:

• Analyzed tumor tissue from 77 patients with various brain tumors, including meningiomas, gliomas, neurinomas, pituitary adenomas, and metastatic brain tumors.
• Measured cytosolic and nuclear ER levels using the dextran-coated charcoal method and Scatchard analysis.
• Assayed ER levels in meningiomas, gliomas, neurinomas, pituitary adenomas, and metastatic brain tumors.

Main Results:

• Cytosolic ER was detected in 100% of pituitary adenomas, 50% of meningiomas, 50% of metastatic brain tumors, 25% of neurinomas, and 15% of gliomas.
• Among gliomas, only medulloblastomas showed ER activity.
• Nuclear ER was found in three premenopausal women with meningioma, with a dissociation constant < 10(-9) M.

Conclusions:

• Estrogen receptor is present in a significant proportion of pituitary adenomas and meningiomas.
• The presence of ER in these brain tumors suggests a potential for estrogen-mediated growth and responsiveness to endocrine therapies.
• Further research is warranted to explore the therapeutic implications of ER presence in brain tumors.